BullFrog AI signs feasibility agreement with top-5 pharma for MDD target discovery

BullFrog AI Holdings, Inc.

Agreement with top-5 global pharma (by 2025 revenue) for bfLEAP platform to identify novel drug targets in major depressive disorder (MDD).
One-year feasibility deal with milestone payments upon delivery of deliverables; client gets exclusive three-year option on a selected final target.
MDD market valued >$8B in 2025, expected ~$11B by 2032, per Stellar Market Research.
CEO Vin Singh calls it 'strong, high-quality validation' and expects the relationship to expand across other R&D areas.
Agreement filed as exhibit; termination clauses allow 30-day notice for no-cause termination from client.

item 1.01 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-013684
form_type: 8-K
ticker: BFRG
cik: 0001829247
company_name: BullFrog AI Holdings, Inc.
filed_at: 2026-03-30T23:59:59+00:00
discovered_at: 2026-05-14T18:02:36.407753+00:00
generated_at: 2026-05-15T08:25:58.613343+00:00
sec_items: ["1.01", "8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-013684
json_url: https://secwatch.observer/filing/0001493152-26-013684.json
markdown_url: https://secwatch.observer/filing/0001493152-26-013684.md
text_url: https://secwatch.observer/filing/0001493152-26-013684.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1829247/000149315226013684/0001493152-26-013684-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1829247/000149315226013684/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-013684

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.